Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT studyGerardo Rosati, Domenico Bilancia, Giorgio Reggiardo et al.|Journal of Geriatric Oncology|2021Cited by 5
Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancerGerardo Rosati, S. Bianco, Raffaele Addeo et al.|Cancer Chemotherapy and Pharmacology|2019Cited by 4
Resilience in Cancer Care at the Time of COVID-19: Practical Approach to the Management of Cancer Patients During the COVID-19 Emergency in a Large Italian Community HospitalAngioletta Lasagna, Paolo Pedrazzoli, Simona Secondino et al.|Unknown|2020Cited by 1
THE RESILIENCE OF ONCOLOGISTS DURING THE EARLY TIME OF THE COVID-19 PANDEMICAngioletta Lasagna, Paolo Pedrazzoli, Simona Secondino et al.|Annals of Research in Oncology|2021Cited by 1
Validation of a new prognostic body composition parameter in cancer patients.Paolo Pedrazzoli, Emanuele Cereda, Riccardo Caccialanza et al.|Journal of Clinical Oncology|2019Cited by 0